about
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...
Read More
12.68
-0.08
(-0.63%)
6.1M
XNAS Volume
XNAS 12 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Viatris is on 13 Jan 2026 for the purpose of Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
See details
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks
View Similar
Embed DVM
Viatris Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..